Matthew Fusco
Chief Operating Officer
Matt joined BioSymetrics in January 2021, with a background in accounting. He spent 5 years at PwC doing auditing and consulting, before transitioning to the early stage tech company space in 2004. He has held business development and operational roles with companies looking to bring innovative solutions to market. He co-founded a data company offering identity solutions to the advertising ecosystem, and successfully took it through a sale to Claritas in 2018.
“BioSymetrics brings together two massive, exciting industries: AI/Maching Learning and BioPharma. I always gravitated towards companies that were doing something new and big. To date, there has not been anything bigger and more exciting than what BioSymetrics is doing, not only because of the size of the market but more importantly because of the good that it can bring about in people's lives via more efficient and effective drug discovery.”
— Matt Fusco